Please note that the recruitment of patients to VIABLE clinical trial was successfully completed.

OK

View the Map

Participating Medical Centers

You have entered website for VIABLE study – phase III global clinical trial for prostate cancer treatment (DCVAC/PCa). This clinical trial is intended for patients with metastatic castration- resistant prostate cancer, who meet the entry criteria and consent to participate.

Only a physician conducting a clinical evaluation of an investigational treatment DCVAC/PCa can decide whether or not a patient can be included in a clinical trial. This is based on the criteria defined in the study protocol which is approved by the health care authorities.

The term “investigational treatment” means that it has not yet been approved by the European Medicines Agency (EMA) or Food and Drug Administration (FDA) for the treatment of prostate cancer.

You can find the participating medical centres listed below.

Hungary

Participating Medical Center Address Principal investigator Phone  
Bajcsy-Zsilinszky Kórház és Rendelőintézet, Urológiai Osztály
Maglódi út 89-91,
H-1106 Budapest
Dr. Géza Böszörményi-Nagy +36 1 432 7734 E-mail
Egyesített Szent István és Szent László Kórház,
Onkológiai Osztály
Gyáli út 5-7,
H-1097 Budapest
Prof. Dr. György Bodoky +36 1 455 8273 E-mail
Magyar Honvédség Egészségügyi Központ,
Onkológiai Osztály
Podmaniczky utca 111,
H-1062 Budapest
Dr. Zsuzsanna Pápai +36 1 475 2638 E-mail
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Rendelőintézet, Onkológiai Osztály
Tószegi út 21,
H-5004 Szolnok
Dr. Tibor Csőszi +36 5 650 3669 E-mail